Literature DB >> 19935144

On cholesterol levels and statins in cognitive decline and Alzheimer disease: progress and setbacks.

Marwan N Sabbagh, Kabir Thind, David Larry Sparks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19935144      PMCID： PMC2784643          DOI： 10.1097/WAD.0b013e3181a80242

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN： 0893-0341            Impact factor:   2.703


× No keyword cloud information.
  39 in total

1.  Is there a characteristic lipid profile in Alzheimer's disease?

Authors:  Marwan Sabbagh; H Reza Zahiri; Joanne Ceimo; Kimbal Cooper; William Gaul; Donald Connor; D Larry Sparks
Journal:  J Alzheimers Dis       Date:  2004-12       Impact factor: 4.472

2.  Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

Authors:  D Larry Sparks; Marwan N Sabbagh; Donald J Connor; Jean Lopez; Lenore J Launer; Patrick Browne; Dawn Wasser; Sherry Johnson-Traver; Jeff Lochhead; Chuck Ziolwolski
Journal:  Arch Neurol       Date:  2005-05

3.  Statin use and the risk of incident dementia: the Cardiovascular Health Study.

Authors:  Thomas D Rea; John C Breitner; Bruce M Psaty; Annette L Fitzpatrick; Oscar L Lopez; Anne B Newman; William R Hazzard; Peter P Zandi; Gregory L Burke; Constantine G Lyketsos; Charles Bernick; Lewis H Kuller
Journal:  Arch Neurol       Date:  2005-07

4.  Cholesterol, transferrin saturation, and the development of dementia and Alzheimer's disease: results from an 18-year population-based cohort.

Authors:  Arch G Mainous; Stephanie L Eschenbach; Brian J Wells; Charles J Everett; James M Gill
Journal:  Fam Med       Date:  2005-01       Impact factor: 1.756

Review 5.  Gene-environment interaction in Alzheimer's disease: a potential role for cholesterol.

Authors:  V Chandra; R Pandav
Journal:  Neuroepidemiology       Date:  1998       Impact factor: 3.282

6.  APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.

Authors:  C Dufouil; F Richard; N Fiévet; J F Dartigues; K Ritchie; C Tzourio; P Amouyel; A Alpérovitch
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

7.  Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

Authors:  G Li; R Higdon; W A Kukull; E Peskind; K Van Valen Moore; D Tsuang; G van Belle; W McCormick; J D Bowen; L Teri; G D Schellenberg; E B Larson
Journal:  Neurology       Date:  2004-11-09       Impact factor: 9.910

8.  Impact of plasma lipids and time on memory performance in healthy elderly without dementia.

Authors:  C Reitz; J Luchsinger; M-X Tang; J Manly; R Mayeux
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

9.  Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels.

Authors:  Y M Kuo; M R Emmerling; C L Bisgaier; A D Essenburg; H C Lampert; D Drumm; A E Roher
Journal:  Biochem Biophys Res Commun       Date:  1998-11-27       Impact factor: 3.575

10.  Effects of atorvastatin on higher functions.

Authors:  G P Parale; N N Baheti; P M Kulkarni; N V Panchal
Journal:  Eur J Clin Pharmacol       Date:  2006-02-18       Impact factor: 2.953
View more
  4 in total

1.  KIF6 719Arg allele is associated with statin effects on cholesterol levels in amnestic mild cognitive impairment and Alzheimer's disease patients.

Authors:  Marwan Sabbagh; Michael Malek-Ahmadi; Ian Levenson; D Larry Sparks
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Interindividual variation in serum cholesterol is associated with regional white matter tissue integrity in older adults.

Authors:  Victoria J Williams; Elizabeth C Leritz; Juli Shepel; Regina E McGlinchey; William P Milberg; James L Rudolph; Lewis A Lipsitz; David H Salat
Journal:  Hum Brain Mapp       Date:  2012-03-22       Impact factor: 5.038

3.  Systematic review of atorvastatin for the treatment of Alzheimer's disease.

Authors:  Yuan Sun; Genfa Wang; Zhihong Pan; Shuyan Chen
Journal:  Neural Regen Res       Date:  2012-06-15       Impact factor: 5.135

4.  Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATP III Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative--Effectiveness Modeling Study.

Authors:  Benjamin Z Galper; Y Claire Wang; Andrew J Einstein
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.